TXNIP and ovarian carcinoma: Further mechanistic analysis indicated that CA induces pyroptosis in ovarian cancer through the CASP4/TXNIP-NLRP3-Gasdermin-D (GSDMD) pathway, thereby inhibiting ovarian cancer cell growth and presenting a potential therapeutic approach (124).